Dihydroergotamine Mesylate and Insulin Aspart Protamine Injection
Determining the interaction of Dihydroergotamine Mesylate and Insulin Aspart Protamine Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Insulin aspart, recombinant Subcutaneous
- Dihydroergotamine Mesylate-Insulin degludec
- Dihydroergotamine Mesylate-Insulin Degludec (U-100) Prefilled Pens
- Dihydroergotamine Mesylate-Insulin Degludec (U-100) Vials
- Dihydroergotamine Mesylate-Insulin Degludec (U-200) Prefilled Pens
- Dihydroergotamine Mesylate-Insulin degludec and liraglutide
- Insulin Aspart Protamine Injection-Dihydroergotamine nasal
- Insulin Aspart Protamine Injection-Dihydroergotamine Nasal Spray
- Insulin Aspart Protamine Injection-Dilacor XR
- Insulin Aspart Protamine Injection-Dilantin
- Insulin Aspart Protamine Injection-Dilantin Infatabs
- Insulin Aspart Protamine Injection-Dilantin injection